Structure-activity relationships of sugar-based peptidomimetics as modulators of amyloid β-peptide early oligomerization and fibrillization

European Journal of Medicinal Chemistry

Volumn 86, Issue , 2014, Pages 752-758

  Kaffy, Julia ^a   Brinet, Dimitri ^a,b   Soulier, Jean Louis ^a   Khemtémourian, Lucie ^c   Lequin, Olivier ^c   Taverna, Myriam ^b   Crousse, Benoît ^a   Ongeri, Sandrine ^a  

^a UNIVERSITÉ PARIS SUD   (France)

^b UNIV PARIS SUD   (France)

^c SORBONNE UNIVERSITÉ   (France)

Author keywords

Alzheimer's disease; Amyloid peptide; Capillary electrophoresis; Glycopeptides; Oligomers; Peptidomimetics

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; HYDROXYL GROUP; OLIGOMER; PENTAPEPTIDE; PEPTIDOMIMETIC AGENT; SUGAR; AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (1-42); CARBOHYDRATE; OLIGOPEPTIDE; PEPTIDE FRAGMENT;

ARTICLE; CAPILLARY ELECTROPHORESIS; FLUORESCENCE SPECTROSCOPY; IN VITRO STUDY; MOLECULAR DYNAMICS; MONITORING; NEUROTOXICITY; OLIGOMERIZATION; PROTEIN AGGREGATION; PROTEIN ASSEMBLY; STRUCTURE ACTIVITY RELATION; TRANSMISSION ELECTRON MICROSCOPY; CHEMISTRY; DRUG EFFECTS; PROTEIN MULTIMERIZATION;

AMYLOID BETA-PEPTIDES; CARBOHYDRATES; OLIGOPEPTIDES; PEPTIDE FRAGMENTS; PEPTIDOMIMETICS; PROTEIN MULTIMERIZATION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84907818449     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2014.09.031     Document Type: Article

References (38)

1. http://www.alz.co.uk/research/world-report.
2. L. Mucke, Alzheimers's disease, Nature 461 (2009) 895-897.
3. M. Goedert, M.G. Spillantini, A century of Alzheimer's disease, Science 314 (2006) 777-780
4. C. Haas, D.J. Selkoe, Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer amyloid b-peptide, Nat. Rev. Mol. Cell Biol. 8 (2007) 101-112.
5. S.I.A. Cohen, S. Linse, M. Luheshi, E. Hellstrand, D.A. White, L. Rajah, D.L. Otzen, M. Vendruscolo, C.M. Dobson, T.P.J. Knowles, Proliferation of amyloid-β42 aggregates occurs through a secondary nucleation mechanism, Proc. Natl. Acad. Sci. U. S. A. 110 (2013) 9758-9763.
6. S. Matsumura, K. Shinoda, M. Yamada, S. Yokojima, M. Inoue, T. Ohnishi, T. Shimada, K. Kikuchi, D. Masui, S. Hashimoto, M. Sato, A. Ito, M. Akioka, S. Takagi, Y. Nakamura, K. Nemoto, Y. Hasegawa, H. Takamoto, H. Inoue, S. Nakamura, Y.-I. Nabeshima, D.B. Teplow, M. Kinjo, M. Hoshi, Two distinct amyloid b-protein (Ab) assembly pathways leading to oligomers and fibrils identified by combined fluorescence correlation spectroscopy, morphology, and toxicity analyses, J. Biol. Chem. 286 (2011) 11555-11562.
7. J.S. Jeong, A. Ansaloni, R. Mezzenga, H.A. Lashuel, G. Dietler, Novel mechanistic insight into the molecular basis of amyloid polymorphism and secondary nucleation during amyloid formation, J. Mol. Biol. 425 (2013) 1765-1781.
8. T. Lührs, C. Ritter, M. Adrian, D. Riek-Loher, B. Bohrmann, H. Döbeli, D. Schubert, R. Riek, 3D structure of Alzheimer's amyloid-β(1-42) fibrils, Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 17342-17347.
9. A. Laganowsky, C. Liu, R.M. Sawaya, J.P. Whitelegge, J. Park, M. Zhao, Atomic view of a toxic amyloid small oligomer, Science 335 (2012) 1228-1231.
10. L. Yu, R. Edalji, J.E. Harlan, T.F. Holzman, A. Pereda Lopez, B. Labkovsky, H. Hillen, S. Barghorn, U. Ebert, P.L. Richardson, L. Miesbauer, L. Solomon, D. Bartley, K. Walter, R.W. Johnson, P.J. Hajduk, E.T. Olejniczak, Structural characterization of a soluble amyloid b-peptide oligomer, Biochemistry 48 (2009) 1870-1877.
11. M. Ahmed, J. Davis, D. Aucoin, D. Sato, S. Ahuja, S. Aimoto, J.I. Elliott, W.E. Van Nostrand, S.O. Smith, Structural conversion of neurotoxic amyloid-β(1-42) oligomers to fibrils, Nat. Struct. Mol. Biol. 17 (2010) 561-567.
12. K.N. Dahlgren, A.M. Manelli, W. Blaine Stine, L.K. Baker, G.A. Krafft, M.J. LaDu, Oligomeric and fibrillar species of amyloid-β peptides differentially affect neuronal viability, J. Biol. Chem. 277 (2002) 32046-32053.
13. A. Jan, O. Gokce, R. Luthi-Carter, H.A. Lashuel, The ratio of monomeric to aggregated forms of Aβ40 and Aβ42 is an important determinant of amyloid-β aggregation, fibrillogenesis, and toxicity, J. Biol. Chem. 283 (2008) 28176-28189.
14. K. Ono, M.M. Condron, D.B. Teplow, Structureeneurotoxicity relationships of amyloid b-protein oligomers, Proc. Natl. Acad. Sci. U. S. A. 106 (2009) 14745-14750.
15. G.M. Shankar, S. Li, T.H. Mehta, A. Garcia-Munoz, N.E. Shepardson, I. Smith, F.M. Brett, M.A. Farrell, M.J. Rowan, C.A. Lemere, C.M. Regan, D.M. Walsh, B.L. Sabatini, D.J. Selkoe, Amyloid b-protein dimers isolated directly from Alzheimer brains impair synaptic plasticity and memory, Nat. Med. 14 (2008) 837-842.
16. P. Prangkio, E.C. Yusko, D. Sept, J. Yang, M. Mayer, Multivariate analyses of amyloid-βeta oligomer populations indicate a connection between pore formation and cytotoxicity, PLoS One 7 (2012) -47261.
17. P. Cizas, R. Budvytyte, R. Morkuniene, R. Moldovan, M. Broccio, M. Lösche, G. Niaura, G. Valincius, V. Borutaite, Size-dependent neurotoxicity of b-amyloid oligomers, Arch. Biochem. Biophys. 496 (2010) 84-92.
18. T. Härd, C. Lendel, Inhibition of amyloid formation, J. Mol. Biol. 421 (2012) 441-465.
19. M. Bartolini, V. Andrisano, Strategies for the inhibition of protein aggregation in human diseases, ChemBioChem 11 (2010) 1018-1035.
20. C.I. Stains, K. Mondal, I. Ghosh, Molecules that target beta-amyloid, Chem- MedChem 2 (2007) 1674-1692.
21. T. Liu, G. Bitan, Modulating self-assembly amyloidogenic proteins as a therapeutic approach for neurodegenerative diseases: strategies and mechanism, ChemMedChem 7 (2012) 359-374.
22. F. Belluti, A. Rampa, S. Gobbi, A. Bisi, Small-molecule inhibitors/modulators of amyloid-β peptide aggregation and toxicity for the treatment of Alzheimer's disease: a patent review (2010-2012), Expert Opin. Ther. Pat. 23 (2013) 581-596.
23. J. Bieschke, M. Herbst, T. Wiglenda, Small-molecule conversion of toxic oligomerts to nontoxic b-sheet-rich amyloid fibrils, Nat. Chem. Biol. 8 (2012) 93-101.
24. M. Necula, L. Breydo, S. Milton, K. Rakez, W.E. van der Veer, P. Tone, C.G. Glabe, Methylene blue inhibits amyloid Ab oligomerization by promoting fibrillization, Biochemistry 46 (2007) 8850-8860.
25. For a review, see (a) Reference 18. (b) T. Takahashi, H. Mihara, Peptide and protein mimetics inhibiting amyloid peptide aggregation, Acc. Chem. Res. 41 (2008) 1309-1318
26. B. Neddenriep, A. Calciano, D. Conti, E. Sauve, M. Paterson, E. Bruno, D.A. Moffet, Short peptides as inhibitors of amyloid aggregation, Open Biotechnol. J. 5 (2011) 39-46.
27. P. Vlieghe, V. Lisowski, J. Martinez, M. Khrestchatisky, Synthetic therapeutic peptides: science and market, Drug Discov. Today 15 (2010) 40-56
28. F. Albericio, H.G. Kruger, Therapeutic peptides, Future Med. Chem. 4 (2012) 1527-1531.
29. B. Dorgeret, L. Khemtemourian, I. Correia, J.-L. Soulier, O. Lequin, S. Ongeri, Sugar-based peptidomimetics inhibit amyloid b-peptide aggregation, Eur. J. Med. Chem. 46 (2011) 5959-5969.
30. S.A.W. Gruner, V. Truffault, G. Voll, E. Locardi, M. Stöckle, H. Kessler, Design, synthesis, and NMR structure of linear and cyclic oligomers containing novel furanoid sugar amino acids, Chem. Eur. J. 8 (2002) 4366-4376
31. F. Schweizer, Glycosamino acids: building blocks for combinatorial synthesiseimplications for drug discovery, Angew. Chem. Int. Ed. 41 (2002) 230-253
32. M.D.P. Risseueuw, M. Overhand, G.W.J. Fleet, M.I. Simone, A compendium of sugar amino acids (SAA): scaffolds, peptide- and glyco-mimetics, Tetrahedron Asymmetry 18 (2007) 2001-2010.
33. H. LeVine 3rd, Quantification of b-sheet amyloid fibril structures with thioflavin T, Methods Enzymol. 309 (1999) 274-284.
34. D. Brinet, J. Kaffy, F. Oukacine, S. Glumm, S. Ongeri, M. Taverna, An improved CE method for the in vitro monitoring of the challenging early steps of the Ab1-42 peptide oligomerization: application to anti-Alzheimer's drug discovery, Electrophoresis (2014) (in press).
35. M.D. Smith, L. Cruz, Changes to the structure and dynamics in mutations of Ab21-30 caused by ions in solution, J. Phys. Chem. B 117 (2013) 14907-14915
36. K. Hochdörffer, J. März-Berberich, L. Nagel-Steger, M. Epple, W. Meyer- Zaika, A.H.C. Horn, H. Sticht, S. Sinha, G. Bitan, T. Schrader, Rational design of b-sheet ligands against Aβ42-induced toxicity, J. Am. Chem. Soc. 133 (2011) 4348-4358.
37. S. Sabella, M. Quaglia, C. Lanni, M. Racchi, S. Govoni, G. Caccialanza, A. Calligaro, V. Bellotti, E. De Lorenzi, Capillary electrophoresis studies on the aggregation process of b-amyloid 1-42 and 1-40 peptides, Electrophoresis 25 (2004) 3186-3194.
38. S. Butini, M. Brindisi, S. Brogi, S. Maramai, E. Guarino, A. Panico, A. Saxena, V. Chauhan, R. Colombo, L. Verga, E. De Lorenzi, M. Bartolini, V. Andrisano, E. Novellino, G. Campiani, S. Gemma, ACS Med. Chem. Lett. 4 (2013) 1178-1182.